<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01959321</url>
  </required_header>
  <id_info>
    <org_study_id>HD36801-HCV</org_study_id>
    <secondary_id>U10HD036801</secondary_id>
    <secondary_id>UG1HD087230</secondary_id>
    <secondary_id>UG1HD027869</secondary_id>
    <secondary_id>UG1HD027915</secondary_id>
    <secondary_id>UG1HD034208</secondary_id>
    <secondary_id>UG1HD040500</secondary_id>
    <secondary_id>UG1HD040485</secondary_id>
    <secondary_id>UG1HD053097</secondary_id>
    <secondary_id>UG1HD040544</secondary_id>
    <secondary_id>UG1HD040545</secondary_id>
    <secondary_id>UG1HD040560</secondary_id>
    <secondary_id>UG1HD040512</secondary_id>
    <secondary_id>UG1HD068282</secondary_id>
    <secondary_id>UG1HD068258</secondary_id>
    <secondary_id>UG1HD068268</secondary_id>
    <secondary_id>UG1HD034116</secondary_id>
    <secondary_id>UG1HD087192</secondary_id>
    <nct_id>NCT01959321</nct_id>
  </id_info>
  <brief_title>An Observational Study of Hepatitis C Virus in Pregnancy</brief_title>
  <acronym>HCV</acronym>
  <official_title>An Observational Study of Hepatitis C Virus in Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The George Washington University Biostatistics Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The George Washington University Biostatistics Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-center observational study examines risk factors for HCV transmission from mother
      to baby.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This multi-center observational study examines risk factors for HCV transmission from mother
      to baby. The study will also assess risk factors associated with Hepatitis C Virus (HCV)
      infection in pregnant women. Also, the study will describe the outcomes of pregnant women
      with HCV as well as the outcomes of their infants to 18 months of age.

      Approximately 750 HCV antibody positive pregnant women and their infants will be followed
      from baseline until the infant is 18 months. A randomly selected control cohort of 500
      pregnant women who are HCV antibody negative will be followed until delivery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HCV infection of the offspring</measure>
    <time_frame>at 2 months and/or 18 months of age</time_frame>
    <description>The primary outcome is HCV infection of the offspring, where infection is defined by satisfying any one of the following criteria:
HCV RNA positive (i.e. presence of viral load) by polymerase chain reaction (PCR) test at 2-6 months (2 month visit)
HCV RNA positive and HCV antibody positive at the 18-24 months (18 month visit)
HCV RNA positive at 18-24 months with a negative HCV antibody at 18-24 months and negative RNA at 2-6 months. However, the positive result must be confirmed by a repeat test on the 18-month sample to qualify.
HCV antibody positive at 18-24 months with negative HCV RNA at both visits. However, the positive result must be confirmed by a repeat test on the 18-month sample to qualify.
Clinical result that is either HCV RNA positive or HCV antibody positive obtained at 18 months or older with a confirmed clinical diagnosis of HCV, if a central laboratory sample could not be obtained at 18-24 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age at delivery</measure>
    <time_frame>at birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm delivery &lt; 37 weeks of gestation</measure>
    <time_frame>at birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational diabetes mellitus (GDM)</measure>
    <time_frame>during pregnancy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal bleeding during pregnancy</measure>
    <time_frame>during pregnancy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preeclampsia</measure>
    <time_frame>during pregnancy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholestasis</measure>
    <time_frame>during pregnancy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Viral load in infant</measure>
    <time_frame>at birth, 2 months, and 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HCV antibody status in infant</measure>
    <time_frame>at 18 months of age</time_frame>
    <description>positive or negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth weight of infant</measure>
    <time_frame>at birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperbilirubinemia</measure>
    <time_frame>at birth</time_frame>
    <description>Peak total bilirubin of at least 15 mg% or the use of phototherapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal intensive care unit (NICU) admission</measure>
    <time_frame>at birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Small for gestational age</measure>
    <time_frame>at birth</time_frame>
    <description>Defined as less than the 5th percentile birth weight for gestational age at birth, assessed specifically by sex and race of the infant based on United States birth certificate data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal infections</measure>
    <time_frame>at birth</time_frame>
    <description>sepsis and pneumonia</description>
  </secondary_outcome>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Hepatitis C</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      maternal serum maternal plasma infant serum infant plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with singleton pregnancies presenting for prenatal care prior to 23 weeks, 6 days
        gestation at Maternal-Fetal Medicine Units (MFMU) Network hospital sites.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Singleton pregnancy

          2. An HCV antibody positive screen (case) measured using two FDA-approved ELISA tests,
             the Abbott Architect version 3.0 system and the Ortho HCV 3.0.

          3. Gestational age at screening no later than 23 weeks and 6 days, and gestational age at
             enrollment no later than 27 weeks and 6 days, based on clinical information and
             evaluation of the earliest ultrasound as described below.

        Exclusion Criteria:

          1. Planned termination of pregnancy

          2. Known major fetal anomalies or demise

          3. Intention of the patient or the managing obstetricians for the delivery to be outside
             a MFMU Network center, unless special provisions are made to insure infant follow-up
             at two and 18 months of age.

          4. Participation in this study in a previous pregnancy.

          5. Unwilling or unable to commit to 18 months of follow-up for HCV positive infants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uma Reddy, MD, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth A Thom, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The George Washington University Biostatistics Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mona Prasad, DO, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Uma Reddy, MD</last_name>
    <phone>301-496-1074</phone>
    <email>uma.reddy@nih.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama - Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacy Harris, BSN</last_name>
      <phone>205-996-6262</phone>
      <email>stacylharris@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Alan TN Tita, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305-5317</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail Mallett, RN BSN CCRC</last_name>
      <phone>312-503-3200</phone>
      <email>g-mallett@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>William Grobman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Debra McLaud, RN</last_name>
      <phone>617-414-5813</phone>
      <email>debra.mclaud@bmc.org</email>
    </contact>
    <investigator>
      <last_name>Steven Pelton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Bousleiman, RNC MSN MPH</last_name>
      <phone>212-305-4348</phone>
      <email>sb1080@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Cynthia Gymafi-Bannerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina - Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Clark, RN</last_name>
      <phone>919-350-6117</phone>
      <email>kelly_clark@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>John M Thorp, Jr., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Dalton, RNC</last_name>
      <phone>216-778-7533</phone>
      <email>wdalton@metrohealth.org</email>
    </contact>
    <investigator>
      <last_name>Edward Chien, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Bartholomew, RN, BSN</last_name>
      <phone>614-685-3229</phone>
      <email>anna.bartholomew@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Catalin S Buhimschi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Hammond, RN</last_name>
      <phone>215-662-2657</phone>
      <email>Mary.Hammond@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Parry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Magee Women's Hospital of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Bickus, BS, RN</last_name>
      <phone>412-641-4072</phone>
      <email>mbickus@mail.magee.edu</email>
    </contact>
    <investigator>
      <last_name>Hyagriv Simhan, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Allard, RNC</last_name>
      <phone>401-274-1122</phone>
      <email>dallard@wihri.org</email>
    </contact>
    <investigator>
      <last_name>Dwight J Rouse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235-9032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Texas - Galveston</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Salazar, MSN</last_name>
      <phone>409-772-0312</phone>
      <email>assalaza@utmb.edu</email>
    </contact>
    <investigator>
      <last_name>George R Saade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas - Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felecia Ortiz, RN BSN</last_name>
      <phone>713-500-6467</phone>
      <email>Felecia.Ortiz@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Baha Sibai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Hill, RN</last_name>
      <phone>801-585-7645</phone>
      <email>Kim.Hill@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Michael W Varner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2013</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The dataset will be shared per NIH policy after the completion and publication of the main analyses. Requests for datasets can be sent to mfmudatasets@bsc.gwu.edu.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

